drugset / Trial / NCT02547402

A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males

NCT02547402

Phase 1 Completed 10 enrolled Complexa, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This is an exploratory study in a small, well controlled group of healthy subjects to explore the effect of CXA-10 on pravastatin and Vytorin® (combination of simvastatin and ezetimibe).

Timeline

Start
2015-12
Primary completion
2016-01
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CXA-10 Small molecule
Subject Ezetimibe Unknown
Subject Pravastatin Small molecule
Subject Simvastatin Small molecule

Indications